IQV
IQVIA Holdings, Inc. · Healthcare · Diagnostics & Research
TECHNeutralZACKSHold
R500#417 today
$258.21
-0.96% today · -4.50% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- IQV −0.96% on the last session vs SPY +0.74%: −1.7 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 62 big drops in the past 5 years, IQV typically gained 0.4% over the next day (median) and was higher 55% of the time; half the outcomes fell between -1.0% and +1.5%. An ordinary day: -0.0%. Among S&P 500 stocks after big drops, that ranks #113 of 500.
- 2 insider or congressional trades in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 27
Before the open · in 23 days
EPS estimate
$3.27
$3.22 to $3.54 · 17 analysts
Revenue estimate
$4.4B
$4.3B to $4.4B
Track record
8/8 beats
last 8 reports · moved ±7.9% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Jul 28, 2026 BMO | 2Q2026 | $3.03 | $3.15 | +$0.12 (+3.9%) beat | $4.4B | +13.9% +13.7 vs SPY | +10.2% | +9.4% |
| May 5, 2026 BMO | 1Q2026 | $2.82 | $2.90 | +$0.08 (+3.0%) beat | $4.2B | +9.6% +8.8 vs SPY | -0.7% | +7.8% |
| Feb 5, 2026 BMO | 4Q2025 | $3.40 | $3.42 | +$0.02 (+0.7%) beat | $4.4B | -10.7% -9.4 vs SPY | -1.3% | -12.5% |
| Oct 28, 2025 BMO | 3Q2025 | $2.98 | $3.00 | +$0.02 (+0.8%) beat | $4.1B | +0.3% +0.1 vs SPY | -3.3% | -1.6% |
| Jul 22, 2025 BMO | $2.77 | $2.81 | +$0.04 (+1.4%) beat | — | +17.9% +17.9 vs SPY | +7.8% | +24.4% | |
| May 6, 2025 BMO | $2.63 | $2.70 | +$0.07 (+2.7%) beat | — | -4.0% -3.2 vs SPY | -1.6% | +2.5% | |
| Feb 6, 2025 BMO | $3.11 | $3.12 | +$0.01 (+0.3%) beat | — | +2.2% +1.9 vs SPY | +6.2% | -3.7% | |
| Oct 31, 2024 BMO | $2.81 | $2.84 | +$0.03 (+1.1%) beat | — | -4.7% -2.8 vs SPY | -7.3% | +2.4% | |
| Jul 22, 2024 BMO | $2.56 | $2.64 | +$0.08 (+3.1%) beat | — | +9.2% +8.2 vs SPY | +6.8% | +6.7% | |
| May 2, 2024 BMO | $2.48 | $2.54 | +$0.06 (+2.4%) beat | — | -4.6% -5.6 vs SPY | -2.2% | -2.2% | |
| Feb 14, 2024 BMO | $2.82 | $2.84 | +$0.02 (+0.7%) beat | — | +13.1% +12.2 vs SPY | +3.6% | +10.2% | |
| Nov 1, 2023 AMC | $2.45 | $2.49 | +$0.04 (+1.6%) beat | — | +5.8% +3.9 vs SPY | +0.6% | +11.0% | |
| Aug 1, 2023 BMO | $2.37 | $2.43 | +$0.06 (+2.5%) beat | — | -2.1% -1.8 vs SPY | -1.4% | -2.0% | |
| Apr 27, 2023 BMO | $2.41 | $2.45 | +$0.04 (+1.7%) beat | — | -3.3% -5.3 vs SPY | -0.2% | -1.6% | |
| Feb 10, 2023 BMO | $2.76 | $2.78 | +$0.02 (+0.7%) beat | — | -3.2% -3.5 vs SPY | -0.8% | -2.7% | |
| Oct 26, 2022 BMO | $2.38 | $2.48 | +$0.10 (+4.2%) beat | — | +2.2% +3.0 vs SPY | -2.6% | +5.9% | |
| Jul 21, 2022 BMO | $2.38 | $2.44 | +$0.06 (+2.5%) beat | — | +2.3% +1.3 vs SPY | -0.7% | +2.0% | |
| Apr 27, 2022 BMO | $2.42 | $2.47 | +$0.05 (+2.1%) beat | — | +1.7% +1.4 vs SPY | +4.0% | +4.1% | |
| Feb 15, 2022 BMO | $2.43 | $2.55 | +$0.12 (+4.9%) beat | — | -4.7% -6.3 vs SPY | +2.1% | -5.6% | |
| Oct 21, 2021 BMO | $2.12 | $2.17 | +$0.05 (+2.4%) beat | — | +1.3% +1.1 vs SPY | -0.6% | +1.1% | |
| Jul 27, 2021 BMO | $2.08 | $2.13 | +$0.05 (+2.4%) beat | — | — | — | — | |
| Apr 22, 2021 BMO | $1.86 | $2.18 | +$0.32 (+17.2%) beat | — | — | — | — | |
| Feb 10, 2021 BMO | $2.01 | $2.11 | +$0.10 (+5.0%) beat | — | — | — | — | |
| Oct 20, 2020 BMO | $1.54 | $1.63 | +$0.09 (+5.8%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $3.27 (17) | $3.22 – $3.54 | +9% | +0.6% | ▲10 ▼4 | $4.4B | +6% |
| Next quarter · Dec 31, 2026 | $3.65 (17) | $3.58 – $3.81 | +7% | +0.7% | ▲6 ▼8 | $4.5B | +4% |
| Current year · Dec 31, 2026 | $12.97 (22) | $12.87 – $13.38 | +9% | +1.2% | ▲21 ▼0 | $17.4B | +7% |
| Next year · Dec 31, 2027 | $14.47 (22) | $13.90 – $15.48 | +12% | +2.0% | ▲18 ▼2 | $18.5B | +6% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.